Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • About
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “High Bleeding Risk (HBR)”

19 trials

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 19 of 19 results

Large-scale testing (Phase 3)UnknownNCT05903976
What this trial is testing

De-escalating Antiplatelet Therapy to Assess Platelet Reactivity and Outcomes in High Bleeding Risk Patients With Recent ACS

Who this might be right for
Dual Antiplatelet TherapyAcute Coronary SyndromeCoronary Artery Disease
Azienda Ospedaliera Universitaria Policlinico "G. Martino" 200
Not applicableNot Yet RecruitingNCT07354828
What this trial is testing

Optimization and Validation of Quality Control Indicators for Coronary Revascularization Based on Antiplatelet Therapy

Who this might be right for
Acute Coronary Syndrome (ACS)High Bleeding Risk (HBR)Coronary Artery Disease (CAD)
Shenyang Northern Hospital 3,500
Not applicableStudy completedNCT04500912
What this trial is testing

Comparison of the Supraflex Cruz 60 Micron Versus the Ultimaster Tansei 80 Micron in HBR PCI Population

Who this might be right for
Cardiac DiseasePCIHigh Bleeding Risk
Pieter C.Smits 736
Not applicableLooking for participantsNCT06535568
What this trial is testing

Single vs. Dual Antiplatelet Therapy in Elderly or HBR Patients Undergoing Percutaneous Intervention With DCB (PICCOLETO IV-EPIC 38)

Who this might be right for
Coronary DiseaseHeart DiseasesCardiovascular Diseases+22 more
Fondazione Ricerca e Innovazione Cardiovascolare ETS 576
Not applicableStudy completedNCT03815175
What this trial is testing

XIENCE 28 USA Study

Who this might be right for
Bleeding DisorderIschemic StrokeHemorrhagic Stroke+6 more
Abbott Medical Devices 1,605
Not applicableLooking for participantsNCT04814212
What this trial is testing

Drug-Coated Balloon in Anticoagulated and Bleeding Risk Patients Undergoing PCI

Who this might be right for
Coronary Artery Disease
North Karelia Central Hospital 546
Not applicableStudy completedNCT07238764
What this trial is testing

OCT-based DAPT Cessation in HBR Patients

Who this might be right for
High Bleeding Risk PatientsDAPT(Dual Antiplatelet Therapy)Coronary Artery Disease+1 more
Federal State Budgetary Institution, V. A. Almazov Federal North-West Medical Research Centre, of the Ministry of Health 40
Not applicableActive Not RecruitingNCT05221931
What this trial is testing

Drug-Coated Balloon in Patients With High Bleeding Risk

Who this might be right for
Coronary Artery Disease
Samsung Medical Center 1,359
Not applicableNot Yet RecruitingNCT07374718
What this trial is testing

Safety and Efficacy of De-escalation Dual Antiplatelet Therapy After BioFreedom™ Stenting in ACS Patients With Moderate-to-high Ischemic and High Bleeding Risk

Who this might be right for
Acute Coronary Syndrome (ACS)High Bleeding Risk(HBR)Coronary Artery Disease (CAD)
Shenyang Northern Hospital 468
Not applicableUnknownNCT04151680
What this trial is testing

Anticoagulation on Demand After Percutaneous Coronary Intervention in High Bleeding Risk Patients

Who this might be right for
Ischemic Heart DiseaseAtrial Fibrillation
University of Roma La Sapienza 100
Not applicableStudy completedNCT03355742
What this trial is testing

XIENCE 28 Global Study

Who this might be right for
Bleeding DisorderStroke, IschemicStroke Hemorrhagic+6 more
Abbott Medical Devices 963
Not applicableStudy completedNCT03218787
What this trial is testing

XIENCE 90: A Safety Evaluation of 3-month DAPT After XIENCE Implantation for HBR Patients.

Who this might be right for
Coronary Artery Lesions
Abbott Medical Devices 2,047
Not applicableLooking for participantsNCT06657326
What this trial is testing

LEADERS FREE IV (RCT): BioFreedom™ Ultra vs BioFreedom™ in HBR Patients

Who this might be right for
Coronary Artery DiseaseChronic Stable AnginaUnstable Angina+2 more
Biosensors Europe SA 444
Post-approval studies (Phase 4)Study completedNCT04137510
What this trial is testing

Bioflow-DAPT Study

Who this might be right for
Coronary Artery Disease
Biotronik AG 1,948
Not applicableStudy completedNCT03877848
What this trial is testing

EluNIR Ridaforolimus Eluting Coronary Stent System in Patients at High Bleeding Risk (HBR)- EluNIR HBR Study

Who this might be right for
Coronary Stenosis
Medinol Ltd. 319
Post-approval studies (Phase 4)Not Yet RecruitingNCT06763744
What this trial is testing

Genotype-Guided Abbreviated DAPT Versus Un-Guided De-escalation Therapy in Patients With ACS and HBR

Who this might be right for
Acute Coronary Syndrome (ACS) Undergoing Percutaneous Coronary Intervention (PCI)High Bleeding Risk
Samsung Medical Center 3,000
Not applicableNot Yet RecruitingNCT07391358
What this trial is testing

DAPT Strategy in HBR Patients Undergoing Complex PCI Following ACS: Second-Phase Beta Testing of a Patients Decision Aid

Who this might be right for
Acute Coronary Syndrome
Montreal Heart Institute 26
Not applicableStudy completedNCT04138238
What this trial is testing

Cruz HBR Registry - Post-market Registry to Evaluate the Safety and Efficacy of the Supraflex Cruz Stent

Who this might be right for
Coronary Artery Disease
Sahajanand Medical Technologies Limited 1,200
Not applicableEnded earlyNCT04885816
What this trial is testing

Drug-eluting Balloon Versus Drug-eluting Stent for High Bleeding Risk Angioplasty

Who this might be right for
High Bleeding RiskCoronary Artery Disease (CAD)Percutaneous Coronary Intervention (PCI)
Instituto Nacional de Cardiologia Ignacio Chavez 5